Back to Search
MITCHELL BAYNE, MD, MPH
MD, MPH
Student in an Organized Health Care Education/Training Program
NPI: 1831884824Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Characterizing cannabinoid CB2 receptor ligands using DiscoveRx PathHunter beta-arrestin assay.
PMID 19171920·J Biomol Screen·2009
7-preclinical
Phase 1/2 study of fractionated (131)I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy.
PMID 19074729·Blood·2009
3-trial
Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening.
PMID 18198821·J Med Chem·2008
7-preclinical
Novel CDH3 mutations in hypotrichosis with juvenile macular dystrophy.
PMID 17342797·Clin Exp Dermatol·2007
8-other
Three cases of activation of cutaneous squamous-cell carcinoma during treatment with prolonged administration of rituximab.
PMID 16523821·Clin Oncol (R Coll Radiol)·2006
5-case
Can a mathematical formula help define a radiation target volume using positron emission tomography? In regard to Black et al. (Int J Radiat Oncol Biol Phys 2004;60:1272-1282).
PMID 15850948·Int J Radiat Oncol Biol Phys·2005
8-other
Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment.
PMID 16297596·Genomics·2005
4-observational
In regard to Paulino and Johnstone: Use of PET and CT imaging data in radiation therapy planning. Int J Radit Oncol Biol Phys 2004;59:4-5.
PMID 15465222·Int J Radiat Oncol Biol Phys·2004
8-other
Antibody-induced intracellular signaling works in combination with radiation to eradicate lymphoma in radioimmunotherapy.
PMID 14576070·Blood·2004
7-preclinical
Apparent modulation of CD20 by rituximab: an alternative explanation.
PMID 15121717·Blood·2004
8-other
A new anti-idiotype antibody capable of binding rituximab on the surface of lymphoma cells.
PMID 15213098·Blood·2004
7-preclinical
Identification and characterization of a novel RF-amide peptide ligand for orphan G-protein-coupled receptor SP9155.
PMID 12714592·J Biol Chem·2003
7-preclinical
PepPat, a pattern-based oligopeptide homology search method and the identification of a novel tachykinin-like peptide.
PMID 12856286·Mamm Genome·2003
8-other
Cloning and characterization of murine neuromedin U receptors.
PMID 12217421·Peptides·2002
7-preclinical
Molecular modeling and site-specific mutagenesis of the histamine-binding site of the histamine H4 receptor.
PMID 12065753·Mol Pharmacol·2002
8-other
P2Y(13): identification and characterization of a novel Galphai-coupled ADP receptor from human and mouse.
PMID 11961076·J Pharmacol Exp Ther·2002
7-preclinical
Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.
PMID 11413167·J Clin Invest·2001
7-preclinical
ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999.
PMID 11104774·J Biol Chem·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 450 CLARKSON AVE DEPT OF
BROOKLYN, NY 11203 - Phone
- (718) 270-2902
Quick Facts
- NPI
- 1831884824
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile